[研究报告] 数字病理学市场预计将从 2022 年的 9.5262 亿美元增长到 2028 年的 18.924 亿美元;预计 2022 年至 2028 年的复合年增长率为 12.1%。
市场洞察和分析师观点:
数字病理学包括病理信息的获取、管理、共享和解释,包括数字环境中的幻灯片和数据。生成数字幻灯片图像文件,允许对数字病理幻灯片进行高分辨率查看、解释和图像分析。数字病理学允许病理学家以透明和一致的方式快速远程参与、评估和协作,从而提高效率和生产力。数字病理学的未来最终可能包括增强转化研究、计算机辅助诊断 (CAD) 和个性化医疗。数字病理学提供了仅靠玻璃片难以实现的好处,例如改进分析和减少错误。数字病理学的显著优势之一是它可以通过多种方式在短期和长期内提高生产力。
增长动力和挑战:
定期诊断是每种癌症治疗的第一步。借助传统病理学服务,人们只能了解肿瘤细胞的位置;这使得很难共享病例以供第二次审查。使用数字病理学可以对肿瘤进行深入诊断。用于癌症诊断的数字病理学程序通常涉及扫描传统玻璃片,然后将连续的图像以数字方式合并为一个完整的图像,以复制玻璃片上的信息。这些图片与相关的临床/医院或实验室结合在一起,为病理学家提供每种独特癌症状况的综合图片。2017 年 4 月,飞利浦获得 FDA 批准,在美国销售飞利浦 IntelliSite 病理学解决方案,用于主要诊断用途。随着癌症病例数量的不断增加,测试的复杂性和数量也同时增加。飞利浦 IntelliSite 病理学解决方案通过图像创建、查看和管理系统等实现自动化数字病理学,其中包括超快病理幻灯片扫描仪等扫描仪功能。同样,2021 年 1 月,罗氏推出了 CE-IVD 自动化数字病理学算法,该算法能够进行 uPath HER2 Dual ISH 图像分析和 uPath HER2 (4B5) 图像分析,用于乳腺癌诊断,这也有助于医疗保健提供者为每位患者确定最佳治疗策略。人工智能用于图像分析算法,以协助病理学家快速准确地诊断乳腺癌患者。因此,癌症诊断技术的发展正在推动数字病理学市场的增长。
定制研究以满足您的需求
我们可以优化和定制标准产品无法满足的分析和范围。这种灵活性将帮助您获得业务规划和决策所需的准确信息。
数字病理学市场:
复合年增长率(2022 - 2028)12.1%- 2022 年市场规模
9.5262 亿美元 - 市场规模 2028 年
18.924 亿美元
市场动态
- 数字病理系统的技术进步
- 数字病理学在癌症诊断中的应用
- 人工智能的使用
- 数字病理学在药物开发中的应用
关键人物;主力;重要一员
- 荷兰皇家飞利浦公司
- 尼康公司
- 珀金埃尔默公司
- 印度实验室
- 3DHISTECH 有限公司
- 滨松光子学株式会社
- F. 霍夫曼-罗氏有限公司
- 维西奥法姆公司
- 格伦科软件公司
区域概况
- 北美
- 欧洲
- 亚太
- 南美洲和中美洲
- 中东和非洲
市场细分
- 扫描仪
- 软件
- 贮存
- 通信系统
- 人体病理学和兽医病理学
- 药物研发
- 疾病诊断
- 远程会诊
- 培训与教育
- 制药和生物技术公司
- 医院
- 学术
- 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。
报告细分和范围:
“全球数字病理学市场”根据产品、类型、应用、最终用户和地理位置进行细分。根据产品,数字病理学市场细分为扫描仪、软件、通信系统和存储。根据类型,数字病理学市场分为人体病理学和兽医病理学。根据应用,数字病理学市场细分为远程会诊、疾病诊断、药物发现和培训与教育。根据最终用户,数字病理学市场细分为制药和生物技术公司、医院和学术机构。基于地理位置的数字病理学市场细分为北美(美国、加拿大和墨西哥)、欧洲(德国、法国、意大利、英国、俄罗斯和欧洲其他地区)、亚太地区(澳大利亚、中国、日本、印度、韩国和亚太地区其他地区)、中东和非洲(南非、沙特阿拉伯、阿联酋和中东和非洲其他地区)以及南美洲和中美洲(巴西、阿根廷和南美洲和中美洲其他地区)
节段分析:
根据产品,数字病理学市场细分为扫描仪、软件、存储、通信。扫描仪部分在 2021 年占据了最大的市场份额,预计同一部分在预测期内的市场复合年增长率最高,为 12.3%。扫描仪有助于生成快速、可靠和高分辨率的细胞图像。它可以帮助病理学家、组织学家和其他医疗专业人员扫描幻灯片并将图像上传到网络上以供远程访问并与同行协作。扫描仪提供自动细胞成像,用于固定细胞测定和荧光、相差和透射光。技术进步增加了集成软件以及扫描仪,以进一步分析、编辑、管理和共享虚拟幻灯片。例如,2021 年 4 月,领先的端到端数字病理学解决方案提供商 Optra scan 推出了 OS-ultra 320,这是世界上第一台价格实惠的高速数字病理学扫描仪。
病理成像系统使用新的扫描仪技术和病理检查软件将幻灯片数字化。它取代了标准幻灯片和显微镜病理工作流程。病理学家可以通过数字化幻灯片,在精密仪器的帮助下检查病理工作流程的高质量数字照片。该系统可以将图像存储在计算机中,从而改善病理工作流程。因此,病理成像系统市场预计将增长。
根据类型,数字病理学市场细分为人体病理学和兽医病理学。预计人体病理学部分将在 2022 年占据 65.94% 的最大市场份额,预计在预测期内将实现 12.5% 的最高复合年增长率。人体病理学部分增长的主要驱动因素是癌症研究活动的数量不断增加以及研究机构、大学和病理实验室之间日益增多的合作。人体病理学旨在将对人类疾病具有临床病理意义的信息带给实验室和临床医生。它代表了从形态学和临床实验室研究中提取的信息,可直接用于了解人类疾病。它涵盖了患者护理的各个方面,从诊断测试和治疗建议到使用尖端基因技术和预防疾病。
根据应用,数字病理学市场细分为远程会诊、疾病诊断、药物发现和培训与教育。2021 年,药物发现领域可能会占据最大的市场份额,预计未来几年同一领域将以最快的速度增长。数字病理学的优势不仅限于提高速度和准确的结果,它还允许病理学家跨越地理距离展示他们的专业知识,也可以向制药和生物技术公司展示。生物技术和制药公司在临床前研究中总是面临审查和分析数千张幻灯片的问题,数字病理学可以自动进行图像分析,提供对难以管理的大量组织病理学数据的即时和智能访问,最终加快发现过程。公司研究人员可以在互联网上查看数字幻灯片,与当前的单一视野图像查看方法相比,这有很大的改进。
根据最终用户,数字病理学市场细分为制药和生物技术公司、医院和学术机构。制药和生物技术公司部门很可能在 2021 年占据最大的市场份额,但重组疫苗部门预计在预测期内将实现 12.5% 的最高复合年增长率。制药和生物技术公司正在采取主动措施以数字化方式管理其工作;这些公司不断致力于发现药物或疗法的分子和生物标志物。数字病理学通过实现制药公司和研发实验室的数据共享,帮助改变全球制药研究。这些公司通过收集和分析患者病情的数据来评估药物。数字病理学解决方案可帮助这些公司维护记录并有效管理工作流程。例如,安捷伦科技、基因泰克等公司正在与人工智能公司合作,以升级其流程,例如数字化其病理实验室和先进的疗法生产。
区域分析:
根据地理位置,数字病理学市场分为五个主要区域:北美、欧洲、亚太地区、南美和中美以及中东和非洲。由于慢性病负担加重、慢性病管理技术的应用日益广泛、投资不断增加、产品发布不断增加以及市场领导者采取的举措,北美很可能在 2021 年占据全球市场的很大份额。预计美国在预测期内将大幅增长。癌症、阿尔茨海默病等慢性病病例的增加预计将推动数字病理学市场的发展。例如,美国癌症协会 2022 年报告估计,2022 年美国将诊断出约 2,36,740 例新的肺癌病例。同一消息来源还指出,2022 年将报告 79,000 例新的肾癌病例。此外,国际糖尿病联合会 (IDF) 在 2021 年 12 月的报告估计,2021 年墨西哥有 1400 万成年人患有糖尿病。此外,根据加拿大政府于 2021 年 8 月发布的新闻稿,糖尿病是影响加拿大人的主要慢性病,截至 2021 年 8 月,超过 300 万加拿大人和 6.1% 的加拿大成年人患糖尿病的风险很高。癌症的高负担预计将推动对数字病理学的需求,从而推动市场增长。
欧洲是全球细胞开发市场的第二大地区。预测期内,德国在欧洲数字病理学市场中占有最大份额,原因是法国对数字病理学项目、教育和培训计划的支持增加、英国癌症患病率上升和采用数字病理学解决方案以及德国会议数量增加等因素可能会推动欧洲数字病理学市场的增长,这些因素推动了欧洲数字病理学市场的增长。
数字病理学市场报告范围
报告属性 | 细节 |
---|---|
2022 年市场规模 | 9.5262亿美元 |
2028 年市场规模 | 18.924亿美元 |
全球复合年增长率(2022 - 2028) | 12.1% |
历史数据 | 2020-2021 |
预测期 | 2023-2028 |
涵盖的领域 | 按产品
|
覆盖地区和国家 | 北美
|
市场领导者和主要公司简介 |
|
- 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。
行业发展和未来机遇:
以下列出了全球数字病理学市场主要参与者采取的各种举措:
- 2022 年 6 月,SpIntellx, Inc. 与 Inspirata 合作,将 SpIntellx HistoMapr-Breast 平台与 Inspirata 的 Dynamyx 软件整合成一个无缝解决方案。HistoMapr-Breast 是唯一一款利用可解释人工智能 (xAI) 的计算病理学软件,可帮助医疗保健提供者更准确、更有效地诊断、预测和治疗乳腺癌。
- 2022年6月,罗氏获得CE-IVD批准,标志着下一代Ventana DP 600数字病理切片扫描仪问世。
- 2020 年 5 月,丹纳哈 (Leica Biosystems) 在亚太地区推出了其下一代数字病理扫描仪 Aperio GT 450 DX。Aperio GT 450 DX 具有连续加载、无触摸操作和 40 倍放大率下 32 秒的扫描时间,已注册为 CE IVD 和 TGA,可让医疗保健组织扩大数字病理学规模,从而满足不断增长的需求而不会牺牲质量。
- 2020 年 7 月,3DHISTECH PANNORAMIC 扫描仪系列的三个关键成员 PANNORAMIC 250 Flash III、PANNORAMIC Scan II 和 PANNORAMIC Midi II 及其控制软件进行了升级,以更好地满足癌症和药物研究、分子和发育组织学、神经科学等领域的多样化需求。
- 2020 年 8 月,病理学工作流程解决方案的全球领导者 Danahar(徕卡生物系统)宣布在欧洲推出其 Aperio GT 450 DX 数字病理扫描仪。这款下一代成像系统在非常成功的徕卡生物系统数字病理虚拟峰会上亮相,并且已经安装在英国利兹教学医院 NHS 基金会 NHS 的卓越中心。
- 2020 年 10 月,Indica Labs 宣布在美国国家癌症研究所 (NCI) 内正式启动 Indica Labs 软件的企业级云部署,包括 HALO、HALO AI、HALO Link 和 HALO AP。NCI 内数百名用户均可访问该软件,管理数百万张数字图像,并每天分析数千张图像,这是 Indica Labs 软件在全球范围内最大的一次部署。
- 2020 年 5 月,病理学工作流程解决方案的全球领导者 Danahar(Leica Biosystems)和国际医学影像 IT 和网络安全公司 Sectra 宣布合作,以尽快获得美国食品药品管理局 (FDA) 的联合 510(k) 许可。目标是让集成的临床数字病理学解决方案满足学术医疗中心、临床研究组织和大型医院网络等企业级客户的临床需求。
竞争格局和重点公司:
一些知名的数字病理学公司包括荷兰皇家飞利浦公司、尼康公司、珀金埃尔默公司、Indica Labs、3DHISTECH Ltd.、丹纳赫公司、滨松光子学株式会社、F. HOFFMANN-LA ROCHE LTD.、Visiopharm A/S 和 Glencoe Software, Inc 等。这些公司专注于新产品的推出和地域扩张,以满足全球日益增长的消费者需求,并增加其专业产品组合的产品范围。它们在全球拥有广泛的业务,这使它们能够服务于大量客户,从而增加其数字病理学市场份额。
- Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
- PEST and SWOT Analysis
- Market Size Value / Volume - Global, Regional, Country
- Industry and Competitive Landscape
- Excel Dataset
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Digital pathology comprises the gaining, organizing, sharing, and interpretation of pathology information. The process involves converting the glass slides into digital pathology slides using digital pathology scanning solutions. A digital slide image file is then generated, which allows the high-resolution viewing, interpretation, and image analysis of digital pathology slides.
The factors that are driving the growth of the digital pathology market are rising adoption of digital pathology to enhance lab efficiency and the growing applications of digital pathology in drug development and companion diagnostics.
The digital pathology market is expected to be valued at US$ 1892.40 million in 2028.
The CAGR value of the digital pathology market during the forecasted period of 2022-2028 is 12.1%
The Asia Pacific is expected to be the fastest-growing region in the digital pathology market over the forecast period due to growing investments from international players in China and India, increasing disposable income, and growing cancer cases in these regions will show promising growth in the digital pathology market.
The scanner segment is expected to hold the largest share of the market in the global digital pathology market contributing a market share of 55.27% in 2021.
The digital pathology market majorly consists of the players, such as Koninklijke Philips N.V.; Nikon Corporation; Perkin Elmer, Inc.; Indica Labs; 3DHISTECH Ltd.; Hamamatsu Photonics K.K.; F. Hoffmann-La Roche Ltd; Visiopharm A/S; Glencoe Software, Inc.; Danaher Corporation.
The digital pathology market is estimated to be valued at US$ 952.62 million in 2022.
Trends and growth analysis reports related to Life Sciences : READ MORE..
The List of Companies - Digital Pathology Market
- Koninklijke Philips N.V.
- Nikon Corporation
- Perkin Elmer, Inc.
- Indica Labs
- 3DHISTECH Ltd.
- Hamamatsu Photonics K.K.
- F. Hoffmann-La Roche Ltd
- Visiopharm A/S
- Glencoe Software, Inc.
- Danaher Corporation
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.